Qva149 Significantly Lowers The Rate And Risk Of Moderate Or Severe COPD Exacerbation Versus Salmeterol/fluticasone In Patients With Moderate To Severe COPD: The Lantern Study

被引：0
|
作者：
Zhong, N. [1 ]
Wang, C. [2 ]
Zhou, X. [3 ]
Zhang, N. [1 ]
Patalano, F. [4 ]
Humphries, M. [5 ]
Wang, L. [5 ]
Banerji, D. [6 ]
机构：
[1] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China
[2] Third Mil Med Univ, Inst Resp Dis, Xin Qiao Hosp, Chongqing, Peoples R China
[3] Third Mil Med Univ, Southwest Hosp, Dept Resp Med, Chongqing, Peoples R China
[4] Novartis Pharma AG, Basel, Switzerland
[5] Beijing Novartis Pharma Co Ltd, Shanghai, Peoples R China
[6] Novartis Pharmaceut, E Hanover, NJ USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3978
引用
收藏
页数：3
相关论文
共 50 条
  • [11] QVA149 reduces COPD exacerbation rate in various subgroups of patients: The SPARK study
    Ficker, Joachim H.
    Wedzicha, Jadwiga A.
    Decramer, Marc
    FowlerTaylor, Angel
    D'Andrea, Peter
    Arrasate, Christie
    Chen, Hungta
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [12] QVA149 SIGNIFICANTLY IMPROVES LUNG FUNCTION AND SYMPTOMS COMPARED TO TWICE-DAILY FLUTICASONE/SALMETEROL IN COPD PATIENTS: THE ILLUMINATE STUDY
    Kurstjens, N. P.
    Frenzel, C.
    Bateman, E.
    Vogelmeier, C.
    Banerji, D.
    RESPIROLOGY, 2013, 18 : 58 - 58
  • [13] Efficacy And Safety Of Qva149 Versus Glycopyrronium And Tiotropium In Severe To Very Severe COPD: The Spark Study
    Wedzicha, J. A.
    Decramer, M.
    Ficker, J.
    Niewoehner, D. E.
    Sandstrom, T.
    Taylor, A. Fowler
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [14] Efficacy Of Once-Daily Qva149 Compared With Tiotropium Plus Theophylline In Symptomatic Patients With Moderate To Severe COPD
    Kirishi, S.
    Kubo, A.
    Okabayashi, A.
    Akaba, T.
    Takeyama, K.
    Tagaya, E.
    Kondo, M.
    Tamaoki, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [15] Efficacy And Safety Of Qva149 Versus Glycopyrronium And Tiotropium In A Subgroup Of Patients With Severe COPD: The Spark Study
    Wedzicha, J.
    D'Urzo, A. D.
    Decramer, M.
    Ficker, J. H.
    Sandstrom, T.
    Taylor, A. Fowler
    D'Andrea, P.
    Mezzi, K.
    Chen, H.
    Banerji, D.
    Fogel, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [16] Safety And Tolerability Of Qva149, Glycopyrronium And Tiotropium In Patients With Severe To Very Severe COPD: The Spark Study
    Decramer, M.
    Wedzicha, J. A.
    Sandstrom, T.
    Niewoehner, D.
    Taylor, A. Fowler
    D'Andrea, P.
    Arrasate, C.
    Berhane, I.
    Chen, H.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [17] Qva149 Provides Superior Improvement In Lung Function Versus Its Monocomponents In Patients With Moderate-To-Severe COPD: The Flight2 Study
    Kerwin, E. M.
    Ayers, T.
    FowlerTaylor, A.
    Larbig, M.
    Thach, C.
    Maitra, S.
    Patalano, F.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [18] Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD
    Hanania, Nicola A.
    Crater, Glenn D.
    Morris, Andrea N.
    Emmett, Amanda H.
    O'Dell, Dianne M.
    Niewoehner, Dennis E.
    RESPIRATORY MEDICINE, 2012, 106 (01) : 91 - 101
  • [19] Qva149 Reduces Dyspnea In Patients With Moderate-To-Severe COPD As Measured By The Transition Dyspnea Index: The Flight2 Study
    Mahler, D. A.
    Ayers, T.
    FowlerTaylor, A.
    Larbig, M.
    Thach, C.
    Maitra, S.
    Patalano, F.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [20] DUAL-BRONCHODILATION WITH ONCE-DAILY QVA149 IN PATIENTS WITH MODERATE-TO-SEVERE COPD: OVERVIEW OF THE IGNITE PROGRAM
    Price, D.
    Mezzi, K.
    Fedele, M. J.
    Chen, H.
    Banerji, D.
    THORAX, 2013, 68 : A183 - A184
12345